This webinar from Quotient Sciences will explore the existing challenges of managing the manufacture and distribution of clinical trial supplies to numerous sites, in multiple countries, and discuss how to streamline your clinical trial supply chain and accelerate your proof-of-concept timeline.

Learn how to protect your precious API with a logistics strategy that reduces waste and discover how to manage global supply so that you only distribute product where it’s needed, anywhere in the world, when it’s needed.

Key takeaways include:
  • Flexible product presentations and logistics – getting your product delivered as bulk, Brite Stock in primary package, or as patient kits
  • Global “on demand” supply – ensuring distribution where it’s needed, anywhere in the world, when it’s needed.
  • How to avoid stockpiling and product attrition at clinical sites through Brite Stock Inventory Management and Just-in-time labelling and distribution
  • Lean logistics strategies to speed development and reduce waste of API and drug product
  • Understanding of local rules, regulations and managing import and export licensing to avoid hold ups
  • How to exploit efficiencies across protocols and minimize waste through drug pooling

Details About the Webinar

Wednesday, May 26, 2021 · 3:00 p.m. London (GMT +1:00)
Cost: Free
Add to calendar

About the Speakers

1618911306-11afb4fb4c1a8250 Andrew Lewis
VP of Pharmaceutical Sciences, Quotient Sciences

Andy Lewis, BPharm (Hons) MAPS PhD is VP Pharmaceutical Sciences at Quotient Sciences. He leads a team of 120 scientists working on formulation development, clinical manufacturing and pharmaceutical analysis for clients’ drug product programs. He is a member of the Academy of Pharmaceutical Scientists of Great Britain, and has served on the board of directors of the Controlled Release Society (CRS), most recently as secretary.

1618911412-80885c61fc9cf4d3 Nick McEntee
Senior Director of GMP Operations, Quotient Sciences

Nick McEntee has over 23 years’ experience in drug product manufacturing and clinical trial supplies distribution and has experience of development, manufacture and global distribution of a wide range of dosage forms. In his current role, Nick works closely with clients to assist with scoping their clinical trial distribution needs ensuring drug products are manufactured, packaged and labelled to maximize efficiency and flexibility whilst ensuring both clients and ultimately patients’ needs are met through the early phase development program up to proof of concept.